SCHEMBL4065818

SCHEMBL4065818

NC(=O)C1Cc2ccccc2N(CC(=O)NCc2ccccn2)C1=O

nearest known ligand 0.56

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 3/20 0.53
ALOX15 P16050 2/20 0.46
PKM P14618 1/20 0.46
YWHAG P61981 1/20 0.46
NPSR1 Q6W5P4 1/20 0.46
SMN1; SMN2 Q16637 2/20 0.46
KAT2A Q92830 1/20 0.46
KAT2B Q92831 1/20 0.46
ALDH1A1 P00352 1/20 0.45
HPGD P15428 2/20 0.45
MEN1 O00255 2/20 0.45
KMT2A Q03164 2/20 0.45
RECQL P46063 1/20 0.45
GAA P10253 1/20 0.45
L3MBTL1 Q9Y468 1/20 0.45
USP2 O75604 1/20 0.44
RXFP1 Q9HBX9 1/20 0.44
TSHR P16473 1/20 0.44
POLB P06746 1/20 0.44
MAPK1 P28482 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4065824 0.88 KDM4E (0.53) KDM4EALOX15PKMYWHAGNPSR1
SCHEMBL4067884 0.81 PYGL (0.50) KDM4ESMN1; SMN2ALDH1A1GAAL3MBTL1
SCHEMBL4073186 0.78 KDM4E (0.60) KDM4ESMN1; SMN2KAT2AKAT2BALDH1A1
SCHEMBL4066125 0.78 LMNA (0.42) KDM4ESMN1; SMN2ALDH1A1KMT2AGAA
SCHEMBL4068085 0.76 POLB (0.42) KDM4ESMN1; SMN2ALDH1A1HPGDKMT2A
SCHEMBL4068434 0.74 TSHR (0.44) SMN1; SMN2ALDH1A1MEN1KMT2AGAA
SCHEMBL4069562 0.73 CHRM2 (0.48) KDM4ESMN1; SMN2ALDH1A1MEN1KMT2A
SCHEMBL4064789 0.73 POLB (0.47) ALDH1A1L3MBTL1TSHRPOLB
SCHEMBL4064970 0.72 PYGL (0.44) KDM4EALDH1A1MEN1KMT2ATSHR
SCHEMBL4075144 0.72 CHRM2 (0.51) KDM4EALOX15ALDH1A1HPGDMEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20090099176-A1 PYRROLOPYRIDINE-2-CARBOXYLIC ACID AMIDES PROSIDION LIMITED (GB) 2009-04-16 US disclosed
EP-1819332-B1 PYRROLOPYRIDINE-2-CARBOXYLIC ACID AMIDES PROSIDION LTD (GB) 2009-03-11 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090099176-A1 PYRROLOPYRIDINE-2-CARBOXYLIC ACID AMIDES PC, GOT2, PDK1 KDM4E 3425/4885ALOX15 1486/4885PKM 311/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.